 TEL AVIV, Israel, May 14, 2021 GLOBE NEWSWIRE -- InspireMD, Inc. NYSE American: NSPR developer of the CGuardTM Embolic Prevention System EPS for the prevention of stroke caused by the treatment of Carotid Artery Disease CAD, announced today that management will participate at the Investor Summit Conference on May 17, 2021. 